All presentations will need to be recorded ahead of the actual sessions (recording guidelines to be included soon) and the presenter also needs to be present for the duration of the live session during which their presentation is due.
Abstracts are selected to be presented as posters are a critical part of our congress. We are very aware that the virtual experience for poster presentation is inferior to what we can expect from an in person poster session, but we hope that we've devised a solution that will allow you flexibility in the presentation style. Our digital poster presentation experience will allow you to:
Prepare your poster without the constraints of A0 portrait format of a traditional poster, your presentation can take any form you wish from PowerPoint presentation to a more traditional poster.
Record your own presentation, including a narrated PowerPoint, and convert to mp4 to upload as a video.
Take advantage of the platform built-in live chat and direct messaging tools to engage with viewers and connect with attendees (this is not specific to the posters, it can be done generally through the virtual platform).
Non-viral genetic therapy strategies for the treatment of ataxia telangiectasia
James Grey received the ESGCT-sponsored prize for best poster presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about his winning presentation here!
Gene therapy for thrombotic thrombocytopaenic purpura
Robyn Bell received the ESGCT-sponsored prize for best oral presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about her winning presentation here!
CRISPR-Cas9 genome editing - molecular scissors a bit too sharp?
Grégoire Cullot received the ESGCT-sponsored prize for best oral presentation at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about his winning presentation here!
Dgkk as a new therapeutic target in the Fmr1-KO murine model of Fragile X
Karima Habbas received the ESGCT-sponsored prize for best poster at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about her winning presentation here!